Cargando…
HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
BACKGROUND: The quantitative relationship between HER2 copy number and prognosis in HER2 positive adjuvant setting remain controversial, and few studies have focused on adjuvant setting to illustrate the potential clinical relevance of HER2 in cfDNA. Our study aim to develop a novel method in HER2 q...
Autores principales: | Chen, Xiaobin, Lin, Yuxiang, Jiang, Zhengwen, Li, Yan, Zhang, Yihua, Wang, Ying, Yu, Feng, Guo, Wenhui, Chen, Lili, Chen, Minyan, Zhang, Wenzhe, Wang, Chuan, Fu, Fangmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850316/ https://www.ncbi.nlm.nih.gov/pubmed/35158152 http://dx.doi.org/10.1016/j.breast.2022.02.002 |
Ejemplares similares
-
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis
por: Chen, Lili, et al.
Publicado: (2023) -
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023) -
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
por: Liu, Zimin, et al.
Publicado: (2021) -
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022) -
Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)